Killer cell inhibitory receptor interactions with HLA class I molecules - Implications for alloreactivity and transplantation

被引:11
作者
Young, NT
Bunce, M
Morris, PJ
Welsh, KI
机构
[1] Nuffield Department of Surgery, University of Oxford, Oxford
[2] Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Headington
关键词
D O I
10.1016/S0198-8859(96)00258-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human killer cell inhibitory receptors (KIR) are novel members of the immunoglobulin superfamily of cell surface glycoproteins, which are expressed by lymphocytes with natural killer (NK) and cytotoxic T-cell (CTL) phenotypes. These receptors have specificity for relatively conserved epitopes of HLA-A, -B, and -C class I antigens. Recent studies have identified KIR as being involved in the transmission of negative, inhibitory signaling events to the cytotoxic cell which prevent or diminish target cell lysis. KIR are thus likely to play an important role in the responses of alloreactive NK cells and CTL to allogeneic HLA antigens. In this article, we review the known structural and functional characteristics of KIR, suggest a possible mechanism for the transmission of intracellular negative signaling by these receptors, and discuss the relevance of KIR function and HLA specificity to the clinical transplantation of allogeneic tissues. (C) American Society Jar Histocompatibility and Immunogenetics, 1997.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 109 条
  • [1] Natural killer (NK)-cell function and antileukemic activity of a large population of CD3(+)/CD8(+) T cells expressing NK receptors for major histocompatibility complex class I after ''three-loci'' HLA-incompatible bone marrow transplantation
    Albi, N
    Ruggeri, L
    Aversa, F
    Merigiola, C
    Tosti, A
    Tognellini, R
    Grossi, CE
    Martelli, MF
    Velardi, A
    [J]. BLOOD, 1996, 87 (09) : 3993 - 4000
  • [2] Baker E, 1995, CHROMOSOME RES, V3, P511
  • [3] Barber LD, 1996, J IMMUNOL, V156, P3275
  • [4] BEATTY PG, 1993, BLOOD, V81, P249
  • [5] The human leukocyte antigen (HLA)-C-specific ''activatory'' or ''inhibitory'' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
    Biassoni, R
    Cantoni, C
    Falco, M
    Verdiani, S
    Bottino, C
    Vitale, M
    Conte, R
    Poggi, A
    Moretta, A
    Moretta, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) : 645 - 650
  • [6] Bishara A, 1995, EXP HEMATOL, V23, P1667
  • [7] BONNEVILLE M, 1988, J IMMUNOL, V141, P4187
  • [8] THE HUMAN NATURAL-KILLER-CELL RECEPTOR FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES - SURFACE MODULATION OF P58 MOLECULES AND THEIR LINKAGE TO CD3 ZETA-CHAIN, FC-EPSILON-RI GAMMA-CHAIN AND THE P56(LCK) KINASE
    BOTTINO, C
    VITALE, M
    OLCESE, L
    SIVORI, S
    MORELLI, L
    AUGUGLIARO, R
    CICCONE, E
    MORETTA, L
    MORETTA, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) : 2527 - 2534
  • [9] BUELOW R, 1995, TRANSPLANTATION, V59, P455
  • [10] Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
    Bunce, M
    ONeill, CM
    Barnardo, MCNM
    Krausa, P
    Browning, MJ
    Morris, PJ
    Welsh, KI
    [J]. TISSUE ANTIGENS, 1995, 46 (05): : 355 - 367